Management of a patient diagnosed with ovarian cancer during pregnancy

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Insufficient diagnosis of ovarian tumors during pregnancy and decreased oncological alertness constitute huge problems that can subsequently have an unfavorable outcome for both the pregnant woman and the fetus. The difficulties of diagnosing and treating ovarian cancer during pregnancy were demonstrated on the following clinical case example. In pregnant patient A. at 19-20 weeks of pregnancy, a lesion was found in the area of the right appendages (100.9 × 55.4 × 93.4 mm, V = 273 cm3), with many tissue partitions and parietal tissue inclusions. The growth of the neoplasm was noted (CA-125 884 U / ml) and the pain syndrome occurred in the patient at 23-24 weeks of pregnancy. Magnetic resonance imaging revealed a solid-cystic neoplasm of the right ovary (cystadenoma?) and surgery was performed in November 2019. Based on the results of histological examination, a high-grade serous ovarian cancer was diagnosed without signs of microsatellite instability MSI-H/dMMR (in the right ovary, in the biopsy of the left fallopian tube). The patient. received two cycles of polychemotherapy (TC scheme). The treatment was tolerated satisfactorily (CA-125 287.3 U / ml). At a gestational age of 34 6/7 weeks (January 2020), a simultaneous operation was performed, including a lower midline laparotomy, a lower uterine segment caesarean section, extirpation of the uterus with appendages, and an omentectomy. A boy was born (weight 2280 g, height 44 cm) with the Apgar score of 7/7 points, with no complications noticed in the postpartum period. Postoperative histological examination showed metastasis of carcinoma in the left ovary with signs of therapeutic pathomorphosis. The treatment was completed in March 2020 after six cycles of polychemotherapy.

About the authors

Anna E. Protasova

V.A. Almazov National Medical Research Centre; Saint Petersburg State University; North-Western State Medical University named after I.I. Mechnikov; AVA-PETER Ltd.

Author for correspondence.
Email: protasova1966@yandex.ru
SPIN-code: 4097-0969

MD, Dr. Sci. (Med.), Professor

Russian Federation, Saint Petersburg

Irina E. Zazerskaya

V.A. Almazov National Medical Research Centre

Email: zazera@mail.ru
SPIN-code: 5683-6741

MD, Dr. Sci. (Med.)

Russian Federation, Saint Petersburg

Anna A. Tsypurdeyeva

Saint Petersburg State University; AVA-PETER Ltd.; The Research Institute of Obstetrics, Gynecology, and Reproductology named after D.O. Ott

Email: tsypurdeeva@mail.ru
SPIN-code: 5208-9707

MD, Cand. Sci. (Med.)

Russian Federation, Saint Petersburg

Ekaterina S. Shelepova

V.A. Almazov National Medical Research Centre

Email: shelepowa@gmail.com
SPIN-code: 9474-1351

MD, Cand. Sci. (Med.)

Russian Federation, Saint Petersburg

Elena D. Vyshedkevich

V.A. Almazov National Medical Research Centre

Email: lenavish04@gmail.com
SPIN-code: 5856-6500
Russian Federation, Saint Petersburg

Inna A. Rizhinashvili

V.A. Almazov National Medical Research Centre

Email: innaenuk@gmail.com
Russian Federation, Saint Petersburg

Alyona А. Sokolova

V.A. Almazov National Medical Research Centre

Email: alyona-sokolova@mail.ru
SPIN-code: 2423-0370
Russian Federation, Saint Petersburg

References

  1. Leiserowitz GS, Xing G, Cress R, et al. Adnexal masses in pregnancy: how often are they malignant? Gynecol Oncol. 2006;101(2):315–321. doi: 10.1016/j.ygyno.2005.10.022
  2. Schmeler KM, Mayo-Smith WW, Peipert JF, et al. Adnexal masses in pregnancy: surgery compared with observation. Obstet Gynecol. 2005;105(5 Pt 1):1098–1103. doi: 10.1097/01.AOG.0000157465.99639.e5
  3. Smith LH, Dalrymple JL, Leiserowitz GS, et al. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol. 2001;184(7):1504–1513. doi: 10.1067/mob.2001.114867
  4. FIGO news. International Federation of Gynecology and Obstetrics. Treating cancer during pregnancy. [cited 2021 Apr 25]. Available from: https://www.figo.org/news/treating-cancer-during-pregnancy-0016145
  5. Goff BA, Mandel LS, Melancon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004;291(22):2705–2712. doi: 10.1001/jama.291.22.2705
  6. Goff BA, Mandel LS, Drescher CW, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 2007;109(2):221–227. doi: 10.1002/cncr.22371
  7. Palmer J, Vatish M, Tidy J. Epithelial ovarian cancer in pregnancy: a review of the literature. BJOG. 2009;116(4):480–491. doi: 10.1111/j.1471-0528.2008.02089.x
  8. Domini D, Campagna G, Coianiz A, et al. Mucinous adenocarcinoma of the ovary in pregnancy. Minerva Ginecol. 1999;51(3):99–101.
  9. Burke TW, Gershenson DM, Morris M, et al. Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma. Gynecol Oncol. 1994;55(1):47–50. doi: 10.1006/gyno.1994.1245
  10. ESMO European Society for Medical Oncology. ECC 2015 Press prelease: a cancer diagnosis while pregnant should not lead to treatment delay or pregnancy termination. [cited 2021 Apr 25]. Available from: https://www.esmo.org/Conferences/Past-Conferences/European-Cancer-Congress-2015/News/A-Cancer-Diagnosis-While-Pregnant-Should-Not-Lead-to-Treatment-Delay-or-Pregnancy-Termination

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Magnetic resonance imaging. T2-WI in coronal (a) and sagittal (b) planes showing a cystic-solid formation of the right ovary (arrow)

Download (130KB)
3. Fig. 2. Gross specimen: right appendages, omentum biopsy sample

Download (146KB)
4. Fig. 3. Magnetic resonance tomograms, weighted by T2, in the axial (a) and coronal (b) planes, showed a solid neoplasm of the left ovary, 19 × 14 × 12 mm in size

Download (125KB)

Copyright (c) 2021 Eсо-Vector



Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).